These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9731048)

  • 21. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
    Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of elderly hairy cell leukemia patients treated with cladribine.
    Hermel DJ; Cheng B; Bhangoo MS; Burian C; Waalen J; Saven A
    Ann Hematol; 2022 May; 101(5):1089-1096. PubMed ID: 35218397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2'-deoxycoformycin.
    Saven A; Piro LD
    Ann Intern Med; 1993 Aug; 119(4):278-83. PubMed ID: 8101069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience.
    Chadha P; Rademaker AW; Mendiratta P; Kim B; Evanchuk DM; Hakimian D; Peterson LC; Tallman MS
    Blood; 2005 Jul; 106(1):241-6. PubMed ID: 15761021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy.
    Gillis S; Amir G; Bennett M; Polliack A
    Eur J Haematol; 2001 Jan; 66(1):7-10. PubMed ID: 11168501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hairy cell leukemia with cladribine].
    Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
    Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
    Else M; Dearden CE; Catovsky D
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Outcomes Of Patients With Hairy Cell Leukaemia; A 16-Year Experience At A Tertiary Care Center In Pakistan.
    Yousaf M; Khan MA; Iftikhar R; Chaudary QU; Shahbaz N; Ahmad U; Javed H
    J Ayub Med Coll Abbottabad; 2022; 34(4):797-801. PubMed ID: 36566402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
    Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S
    Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.
    Dearden CE; Else M; Catovsky D
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():21-4. PubMed ID: 21599603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
    Else M; Dearden CE; Matutes E; Forconi F; Lauria F; Ahmad H; Kelly S; Liyanage A; Ratnayake V; Shankari J; Whalley I; Catovsky D
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():75-8. PubMed ID: 21504288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-alpha is a very effective salvage therapy for patients with hairy cell leukemia relapsing after cladribine: a report of three cases.
    Hoffman MA
    Med Oncol; 2011 Dec; 28(4):1537-41. PubMed ID: 20509009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience.
    Broccoli A; Argnani L; Nanni L; Terragna C; Sabattini E; Gabrielli G; Stefoni V; Pellegrini C; Casadei B; Morigi A; Lolli G; Carella M; Coppola PE; Zinzani PL
    Am J Hematol; 2021 Oct; 96(10):1204-1210. PubMed ID: 34245477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience.
    Tallman MS; Hakimian D; Rademaker AW; Zanzig C; Wollins E; Rose E; Peterson LC
    Blood; 1996 Sep; 88(6):1954-9. PubMed ID: 8822913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom.
    Guest JF; Smith H; Sladkevicius E; Jackson G
    Clin Ther; 2009; 31 Pt 2():2398-415. PubMed ID: 20110049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of hairy cell leukemia patients treated with cladribine - a 10-year single-center experience in Pakistan.
    Zahid MF; Mehdi MQ; Ali N
    Hematol Transfus Cell Ther; 2019; 41(2):134-138. PubMed ID: 31084763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of cladribine at Scripps for hairy cell leukemia and current results.
    Torrey ML; Sigal DS; Saven A
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():29-33. PubMed ID: 21504293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.